Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

Breakfast Business with Joe Lynam

Friday's business news

10 Oct 2025

Transcription

Transcript generated automatically by AI and may contain errors.

Chapter 1: What are the key business headlines for Friday?

1.533 - 28.48 Joe Lynam

Breakfast Business with Enterprise Ireland on Newstalk. Good morning and welcome to Breakfast Business and thank you to Barry White. It is Friday the 10th of October at 6.31. Happy National Handbag Day for those of you who mark the occasion. Coming up on today's show we'll be talking about EUVAT regulations and we'll be looking at the business of plastic surgery and all the markets as usual.

0

28.621 - 38.671 Joe Lynam

You can email us business at newstalk.com. But first, let's have a look at the main business stories in the newspapers and websites with the esteemed Kate English, Chief Economist with Deloitte. Good morning to you, Kate.

0

38.711 - 39.552 Kate English

Good morning, Joe.

0

39.993 - 40.994 Joe Lynam

Any plans for the weekend?

0

42.235 - 45.439 Kate English

I am meeting friends for dinner and that's about it.

45.459 - 47.2 Joe Lynam

You're not going out on the yacht tonight?

47.881 - 51.825 Kate English

Not going out on the yacht tonight, no. Maybe next, when the weather's better.

52.566 - 60.835 Joe Lynam

Saturday, maybe. Let us start with the AIB spend trend. There were a lot of sporting events and cultural events which spiked our spending.

60.815 - 86.97 Kate English

Yes. So AIB card spending data released today and what we saw in it was a 10% year on year increase in September 2025. But there was huge variations within that spending on groceries is up about 3%, entertainment 12% and ticket sales 45%. If you can guess what drove ticket sales in September? I don't know. Electric picnic sales. Already?

Chapter 2: How did AIB card spending trends change in September?

220.411 - 227.184 Joe Lynam

Novo Nordisk, the maker of Ozempic and Wegovi, it's buying another pharmaceutical group.

0

227.204 - 247.562 Kate English

So reported to buy Acero for up to $5.2 billion to gain, I suppose, access to a... potentially new liver disease drug candidate. And it's the first major deal by the Danish drug makers new CEO that they've had in place since earlier this year.

0

247.582 - 266.115 Kate English

I suppose it's one to watch because when we look across that wider M&A market in the third quarter of this year at a global level, we have seen an increase in global M&A activity. And we're also seeing a bit of movement begin to take place in that European private equity market too.

0

267.117 - 290.48 Kate English

And why I say it's one to watch is remember, this is all happening in an environment of where we have changing global economic forecasts, which often do create uncertainty and pause decision making. But we also do have that decreasing taking place in interest rates. We've had them at the European level for the last year and we're now finally seeing them at a US side as well.

0

290.821 - 292.724 Kate English

So is that increasing that level?

292.744 - 294.527 Joe Lynam

So it's slightly cheaper for people to buy?

294.788 - 305.387 Kate English

Yeah, it's creating a little bit of movement and we are seeing, as I said, that activity across the European market as well. So Novo was one example reported in the news yesterday, but will we see more coming?

305.367 - 313.568 Joe Lynam

And Intel shares, another company of interest here in Ireland, they jumped yesterday on a new chip announcement.

313.808 - 318.821 Kate English

Yeah, so I'm no technology expert, so I'm not going to try and explain fully what this chip is.

Comments

There are no comments yet.

Please log in to write the first comment.